Clinical Trial Update: Comparison of Modafinil and Methylphenidate in Treatment of Excessive Daytime Sleepiness in Patients With Parkinson's Disease [NA]

View source ↗

Summary

A clinical trial comparing modafinil and methylphenidate for excessive daytime sleepiness in Parkinson's disease was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Methylphenidate (Methylphenidate)
• Modafinil (modafinil)

Snippet

Sponsor: US Department of Veterans Affairs | Conditions: Parkinson's Disease | NA | Status: WITHDRAWN